GREEN after Consultant/Specialist initiation. (Decision date - August 2020).
To be used for licensed indications only.
Patients with metastatic prostate cancer will be seen in clinic and will be initiated on bicalutamide. A 3monthly LHRH injection will be issued to the patient to take to the GP for administration between 7-14 days after initiation of bicalutamide.